B2640
DL-丁硫氨酸-(S,R)-亚砜亚胺
synthetic (organic), ≥98% (TLC), γ-glutamylcysteine synthetase inhibitor, powder
登录 查看公司和协议定价
选择尺寸
关于此项目
线性分子式:
CH3(CH2)3S(O)(=NH)CH2CH2CH(NH2)CO2H
化学文摘社编号:
分子量:
222.31
MDL编号:
UNSPSC代码:
12161501
PubChem化学物质编号:
NACRES:
NA.77
产品名称
DL-丁硫氨酸-(S,R)-亚砜亚胺,
生物来源
synthetic (organic)
方案
≥98% (TLC)
表单
powder
mp
215 °C (dec.) (lit.)
溶解性
water: 50 mg/mL, clear to very slightly hazy, colorless to yellow
储存温度
2-8°C
SMILES字符串
CCCCS(=N)(=O)CCC(N)C(O)=O
InChI
1S/C8H18N2O3S/c1-2-3-5-14(10,13)6-4-7(9)8(11)12/h7,10H,2-6,9H2,1H3,(H,11,12)
InChI key
KJQFBVYMGADDTQ-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
一般描述
DL-丁硫氨酸-SR-亚砜亚胺（BSO）是一种氨基酸类似物，可作为γ-谷氨酰半胱氨酸合成酶的抑制剂。BSO可提高克氏锥虫对抗寄生虫药物（如硝呋莫司或苄硝唑）的敏感性。
应用
DL-丁硫氨酸-(S,R)-亚砜亚胺已用于：
- 诱发椋鸟的氧化应激
- 耗竭出生两天的大鼠幼崽中的脉络膜谷胱甘肽(GSH)
- 检测其对克氏锥虫(T. cruzi)的γ-谷氨酰半胱氨酸合成酶和 trypanothione（一种锥虫谷胱甘肽）合成酶(TryS)的抑制作用
DL-丁硫氨酸-(S,R)-亚砜亚胺已被用于消耗视网膜神经节细胞 5 (RGC-5) 细胞系中的细胞谷胱甘肽水平。
生化/生理作用
耗竭细胞谷胱甘肽，下调 GST 级别。
特点和优势
这种化合物是 ADME 毒性研究的特色产品。点击此处发现更多特色 ADME 毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。
警示用语：
Warning
危险声明
危险分类
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
靶器官
Respiratory system
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
Matthew M Harper et al.
Experimental eye research, 89(4), 538-548 (2009-06-16)
The purpose of this study was to determine the viability of cell-based delivery of brain-derived neurotrophic factor (BDNF) from genetically modified mesenchymal stem cells (MSCs) for neuroprotection of RGC-5 cells. RGC-5 cells were differentiated with the protein kinase inhibitor staurosporine
Glutathione: interorgan translocation, turnover, and metabolism
Griffith OW and Meister A
Proceedings of the National Academy of Sciences of the USA, 76(11), 5606-5610 (1979)
Experimental inhibition of a key cellular antioxidant affects vocal communication
Messina S, et al.
Functional Ecology, 1101-1110 (2017)
Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi
Faundez M, et al.
Antimicrobial Agents and Chemotherapy, 49(1), 126-130 (2005)
Masakazu Kakuni et al.
Toxicology letters, 214(1), 9-18 (2012-08-21)
Troglitazone (Tro) is a thiazolidinedione antidiabetic drug that was withdrawn from the market due to its association with idiosyncratic severe liver injury. Tro has never induced liver injury in experimental animals in vivo. It was assumed that the species differences
商品
Discover Bioactive Small Molecules for ADME/Tox
相关内容
Product Information Sheet
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持